EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models

Yanjun Zhang, Jing Sun, Jian Zheng, Suxiang Li, Haiyue Rao, Jun Dai, Zhaoyong Zhang, Yanqun Wang, Donglan Liu, Zhao Chen, Wei Ran, Airu Zhu und 13 weitere

Advanced Science · 2024-03 · 11 (9)

DOI: 10.1002/advs.202303366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.12.2023. Verfasst von Yanjun Zhang und 24 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, th…. Hauptthemen laut MEDLINE: Viral Vaccines, Coronavirus Infections, Middle East Respiratory Syndrome Coronavirus, Nanoparticles. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To combat SARS‐CoV‐2 variants and MERS‐CoV, as well as the potential re‐emergence of SARS‐CoV and spillovers of sarbecoviruses, which pose a significant threat to global public health, vaccines that can confer broad‐spectrum protection against betacoronaviruses (β‐CoVs) are urgently needed. A mosaic ferritin nanoparticle vaccine is developed that co‐displays the spike receptor‐binding domains of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 Wild‐type (WT) strain and evaluated its immunogenicity and protective efficacy in mice and nonhuman primates. A low dose of 10 µg administered at a 21‐day interval induced a Th1‐biased immune response in mice and elicited robust cross‐reactive neutralizing antibody responses against a variety of β‐CoVs, including a series of SARS‐CoV‐2 variants. It is also able to effectively protect against challenges of SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2 variants in not only young mice but also the more vulnerable mice through induction of long‐lived immunity. Together, these results suggest that this mosaic 3‐RBD nanoparticle has the potential to be developed as a pan‐β‐CoV vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viral VaccinesCoronavirus InfectionsMiddle East Respiratory Syndrome CoronavirusNanoparticlesHumansAnimalsMiceAntibodies, NeutralizingAntibodies, ViralSARS-CoV-2Models, Animal

Stichwörter der Autor:innen

mosaic RBD nanoparticle vaccine coronavirus

Substanzen

Antibodies, NeutralizingAntibodies, ViralViral Vaccines

Autor:innen und Institutionen

  • State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
  • Department of Microbiology and Immunology, University of Iowa, Iowa City, IA, 52242, USA.
  • Guangzhou Customs District Technology Center, Guangzhou, 510700, P. R. China.
  • State Key Laboratory of Respiratory Disease, Guangdong Laboratory of Computational Biomedicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, P. R. China.
  • Guangzhou laboratory, Bio-island, Guangzhou, 510320, P. R. China.
  • Institute of Infectious disease, Guangzhou Eighth People's Hospital of Guangzhou Medical University, Guangzhou, 510060, P. R. China.

ORCID-Profile: Jincun Zhao

Förderung

  • Guangdong Basic and Applied Basic Research Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Guangdong Medical Research Foundation
  • National Key R&D Program of China
  • NIAID NIH HHS
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through Animal Disease Management Technology Advancement Sup…
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, Y., Sun, J., Zheng, J., Li, S., Rao, H., Dai, J., Zhang, Z., Wang, Y., Liu, D., Chen, Z., Ran, W., Zhu, A., Li, F., Yan, Q., Wang, Y., Yu, K., Zhang, S., Wang, D., Tang, Y., …, & Zhao, J. (2024). Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models. Advanced Science, 11(9). https://doi.org/10.1002/advs.202303366

Vancouver

Zhang Y, Sun J, Zheng J, Li S, Rao H, Dai J, et al. Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models. Advanced Science. 2024;11(9). doi:10.1002/advs.202303366

BibTeX
@article{Zhang2024,
  author = {Zhang, Yanjun and Sun, Jing and Zheng, Jian and Li, Suxiang and Rao, Haiyue and Dai, Jun and Zhang, Zhaoyong and Wang, Yanqun and Liu, Donglan and Chen, Zhao and Ran, Wei and Zhu, Airu and Li, Fang and Yan, Qihong and Wang, Yiliang and Yu, Kuai and Zhang, Shengnan and Wang, Dong and Tang, Yanhong and Liu, Banghui and Cheng, Linling and Huo, Jiandong and Perlman, Stanley and Zhao, Jingxian and Zhao, Jincun},
  title = {Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {9},
  doi = {10.1002/advs.202303366}
}
Kostenlos starten →